We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · September 27, 2022

Immune Status Does Not Independently Influence Cutaneous SCC Metastasis and Mortality Outcomes When Stratified by Tumor Stage

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual center retrospective cohort analysis of primary N0 disease
J Am Acad Dermatol 2022 Sep 02;[EPub Ahead of Print], DM O'Connor, F Murad, MJ Danesh, W Butler, TD Smile, EO Ilori, BR Gastman, A Vidimos, AB Waldman, CD Schmults, S Koyfman, ES Ruiz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading